Clinical Trial Update: dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact. [NA]

View source ↗

Summary

A clinical trial update evaluating the time course of dMR during first-line treatment of non-small cell lung cancer and its potential prognostic and predictive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Karl Kölbeck | Conditions: Non-small Cell Lung Cancer | NA | Status: UNKNOWN